DUXAP9 and cancer: Other investigations have reported that LINC01296 is overexpressed in PC [37], CMM [27], pancreatic ductal adenocarcinoma (PDAC) [80], and clear cell renal cell carcinoma (ccRCC) [81], which contributes to the initiation and progression of cancers.